News | February 16, 2009

Webinar Reviews the Role of 3D ICE, Mapping in Ablation of Ventricular Outflow Tract Tachycardia

February 16, 2009 - Registration is now open for the Heart Rhythm Society’s free Reality EP Webcast, “Role of 3D ICE and Epicardial Mapping in the Ablation of Ventricular Outflow Tract Tachycardia,” at 7 p.m. EDT Wednesday, March 4.

This new Webcast will feature a panel discussion of an ablation of ventricular outflow tract tachycardia procedure utilizing 3D ultrasound, coronary venous mapping, and percutaneous epicardial mapping in determining the site of origin of the ectopic beats and in guiding ablation.

Expert faculty for this session includes William G. Stevenson, M.D., FHRS; David J. Wilber, M.D., CCDS; and Neil Brysiewicz.

Upon completion of this educational activity, participants will be able to use the surface ECG to identify potential sites of VT origin and plan optimal mapping strategies prior to the procedure. They will also recognize the differences between, and limitations of, both transvenous and percutaneous transpericardial approaches to epicardial mapping of outflow tract VT, and use 3D echo to construct anatomic mapping templates and guide ablation of outflow tract VT.

For more information: www.hrsonline.org


Related Content

News

Oct. 24, 2024 — Medtronic plc has announced United States Food and Drug Administration (FDA) approval of the Affera ...

Home October 30, 2024
Home
News

Oct. 18, 2024 — Boston Scientific Corp. recently announced it has received U.S. Food and Drug Administration (FDA) ...

Home October 21, 2024
Home
News

May 15, 2024 —CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac ...

Home May 15, 2024
Home
News

May 13, 2024 — Innovative Health, Inc. announced that recent growth in single-use device reprocessing has delivered ...

Home May 13, 2024
Home
News

October 10, 2023 — Axon Therapies, a private company focused on addressing a root cause of heart failure, announced 6 ...

Home October 10, 2023
Home
News

August 9, 2023 — Boston Scientific Corporation announced it has received U.S. Food and Drug Administration (FDA) ...

Home August 09, 2023
Home
News

January 31, 2023 —Imricor, a global leader in real-time interventional cardiac magnetic resonance (iCMR) ablation ...

Home January 31, 2023
Home
News

December 21, 2022 — Stereotaxis, a global leader in robotic technologies for the treatment of cardiac arrhythmias ...

Home December 21, 2022
Home
News

October 24, 2022 — Acutus Medical, Inc, an arrhythmia management company focused on improving the way cardiac ...

Home October 24, 2022
Home
News

May 13, 2022 — Acutus Medical, an arrhythmia management company focused on improving the way cardiac arrhythmias are ...

Home May 13, 2022
Home
Subscribe Now